↓ Read PDF
01 · ABSTRACT

Abstract

There is an urgent need for effective antimicrobial agents to treat infected diabetic foot ulcers (DFUs), which are associated with debilitating symptoms, high rates of amputation, long-term disability, elevated mortality, and significant healthcare costs. This need is even more critical in the era of increasing antimicrobial resistance (AMR). Recent IWGDF/IDSA international guidelines recommend "avoiding antibiotics unless there is confirmed bacterial infection and demonstrated susceptibility to the prescribed agents."

↓ Read PDF
02 · PUBLICATION RECORD

Article details

JournalMedical Research Archives
IssueVol 13 No 11 (2025): Vol.13, Issue 11, November 2025
SectionCase Reports
Published02 December 2025
DOI10.18103/mra.v13i11.7020
ISSN2375-1924
03 · RIGHTS & REUSE

Rights & reuse

This article is published under a Creative Commons Attribution License (CC BY 3.0) and may be shared or distributed by anyone as long as attribution is given to the journal.

Authors & affiliations

JG

Jorge Cueto García, MD

American College of Surgeons Department of Surgery, American British Cowdray Hospital of Mexico & Research Department, Anahuac University of Mexico

GO

Gerardo Aparicio Ozores

Chief of Department of Microbiology in National School of Biological Sciences, National Polytechnic Institute of Mexico.

JR

José Moreno Rodríguez

PhD Chemistry, Faculty of Chemistry, National Autonomous University of Mexico. 4 National System of Research.

Medical Research Archives

Submit your own article

Register as an author to reserve your spot in the next issue of the Medical Research Archives.

Start your submission  ↗